FDA OVERSIGHT OF CLINICAL TRIALS The US FDA and regulatory free fall

被引：0

作者：

Wilson, Mark

机构：

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2023年 / 380卷

关键词：

D O I：

10.1136/bmj.p85

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：1

共 50 条

[21] FDA tightens human oversight
Dove, A
NATURE MEDICINE, 2001, 7 (06) : 646 - 646
[22] FDA tightens human oversight
Alan Dove
Nature Medicine, 2001, 7 : 646 - 646
[23] New clinical trials policy at FDA
Vastag, Brian
NATURE BIOTECHNOLOGY, 2006, 24 (09) : 1043 - 1043
[24] FDA to oversee reporting of clinical trials
Mark Ratner
Nature Biotechnology, 2012, 30 : 1163 - 1163
[25] New clinical trials policy at FDA
Brian Vastag
Nature Biotechnology, 2006, 24 : 1043 - 1043
[26] FDA to oversee reporting of clinical trials
Ratner, Mark
NATURE BIOTECHNOLOGY, 2012, 30 (12) : 1163 - 1163
[27] FDA, European Drug Agency Collaborate on Clinical Trial Oversight
不详
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (16): : 1740 - 1740
[28] As Use of Foreign Drug Trials Grows, FDA Oversight May Not Be Keeping Up
Mitka, Mike
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (08): : 843 - 844
[29] Understanding FDA Oversight of Cell Therapies
Smith, Robin L.
GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2012, 32 (20): : 6 - 8
[30] Influence of regulatory systems: A viewpoint of the US FDA process
Cavagnaro, JA
SAFETY EVALUATION OF BIOTECHNOLOGICALLY-DERIVED PHARMACEUTICALS: FACILITATING A SCIENTIFIC APPROACH, 1998, : 31 - 38